Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy

Background Inflammation may contribute to cognitive difficulties in patients with breast cancer. We tested 2 hypotheses: inflammation is elevated in patients with breast cancer vs noncancer control participants and inflammation in patients is associated with worse attention and processing speed over the course of chemotherapy. Methods Serum cytokines (interleukin [IL]-4, 6, 8, 10; tumor necrosis factor [TNF]-alpha) and soluble receptors [sTNFRI, II]) were measured in 519 females with breast cancer before and after chemotherapy and 338 females without cancer serving as control participants. Attention and processing speed were measured by Rapid Visual Processing (RVP), Backward Counting (BCT), and Trail Making-A (TMT-A) tests. Linear regression models examined patient vs control cytokines and receptor levels, adjusting for covariates. Linear regression models also examined relationships between patient cytokines and receptor levels and test performance, adjusting for age, body mass index, anxiety, depression, cognitive reserve, and chemotherapy duration. Statistical tests were 2-sided (alpha = .05). Results sTNFRI and sTNFRII increased over time in patients relative to controls, whereas IL-4, IL-6, and IL-10 decreased. Prechemotherapy, higher IL-8 associated with worse BCT (beta = 0.610, SE = 0.241, P = .01); higher IL-4 (beta = -1.098, SE = 0.516, P = .03) and IL-10 (beta = -0.835, SE = 0.414, P = .04) associated with better TMT-A. Postchemotherapy, higher IL-8 (beta = 0.841, SE = 0.260, P = .001), sTNFRI (beta = 6.638, SE = 2.208, P = .003), and sTNFRII (beta = 0.913, SE = 0.455, P = .045) associated with worse BCT; higher sTNFRII also associated with worse RVP (beta = -1.316, SE = 0.587, P = .03). At prechemotherapy, higher IL-4 predicted RVP improvement over time (beta = 0.820, SE = 0.336, P = .02); higher sTNFRI predicted worse BCT over time (beta = 5.566, SE = 2.367, P = .02). Longitudinally, increases in IL-4 associated with BCT improvement (beta = -0.564, SE = 0.253, P = .03). Conclusions Generally, worse attention and processing speed were associated with higher inflammatory cytokines and receptors and lower anti-inflammatory cytokines in patients; future confirmatory studies are needed.

Automated summary

Inflammation levels are elevated in breast cancer patients during chemotherapy, which is associated with worse attention and processing speed. Lower levels of anti-inflammatory cytokines and higher levels of inflammatory cytokines and receptors are observed in patients. Further confirmatory studies are needed.